WELIREG is administered orally once daily at a standard dose, with provisions for dose adjustments based on adverse reactions and missed dose instructions.

Dosage and Administration Guidelines for WELIREG

Recommended dose: 120 mg orally once daily.

Administration: With or without food, at the same time each day. Tablets should be swallowed whole, not chewed, crushed, or split.

Missed dose: Take as soon as possible on the same day. Resume regular schedule the next day. Do not take extra tablets.

Vomiting: Do not retake the dose. Take the next dose on the next day.

Duration: Until disease progression or unacceptable toxicity.

Dose reductions for adverse reactions:

First reduction: 80 mg once daily.

Second reduction: 40 mg once daily.

Third reduction: Permanently discontinue.

Belzutifan(Welireg)
WELIREG is utilized for adult patients diagnosed with von Hippel-Lindau disease who require systemic therapy for VHL-associated manifestations.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved